Literature DB >> 11181002

Long-term outcome of xenogenic dermal matrix implantation in immunocompetent rats.

E Z DeSagun1, J L Botts, A Srivastava, M Hanumadass, R J Walter.   

Abstract

BACKGROUND: Acellular dermal matrix (ADM) has been used successfully in the treatment of full-thickness skin injuries as an allogenic dermal substitute. To assess the efficacy of xenogenic ADM in such wounds, we examined the long-term wound healing and immunological responses to porcine ADM in a rat model.
MATERIALS AND METHODS: Xenogenic and allogenic ADMs were produced by treating porcine (fresh or cryopreserved) or rat skin with dispase and Triton X-100. Full-thickness skin defects on the rat dorsum were implanted with porcine or rat ADMs and overlaid with split-thickness skin grafts (STSGs). Wounds were evaluated grossly and immunologically at 1, 6, and 12 months after surgery.
RESULTS: Extensive wound contraction was seen in wounds implanted with porcine ADM, but healing was significantly (P < 0.01) better in the rat ADM or STSG groups at 6 and 12 months postsurgery. Sera obtained from porcine ADM-implanted rats reacted strongly with porcine ADM and specifically with the papillary dermis and basal lamina. One month postsurgery, extensive inflammation but few intact mast cells were seen in wounds implanted with porcine ADM and significant (P < 0.02) levels of residual porcine ADM were detectable immunologically. Little inflammation was evident in the STSG or rat ADM groups at any time. Significant lymphocyte proliferation (P < 0.05) occurred in the 6- and 12-month groups in response to porcine, but not rat, ADM.
CONCLUSIONS: In wounds implanted with xenogenic ADM, a short-lived acute inflammatory response, long-lasting humoral and cell-mediated immune responses, and generally poor wound healing were observed.

Entities:  

Mesh:

Year:  2001        PMID: 11181002     DOI: 10.1006/jsre.2000.6060

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  Development and preparation of a low-immunogenicity porcine dermal scaffold and its biocompatibility assessment.

Authors:  Guodong Song; Yan Wu; Fang Wang; Yang Shao; Jinzhu Jiang; Chunjie Fan; Peilong Li; Yonghu Zhang; Haibin Zuo
Journal:  J Mater Sci Mater Med       Date:  2015-03-25       Impact factor: 3.896

2.  Incisional hernia repair in renal transplantation patients.

Authors:  Edward N Li; Ronald P Silverman; Nelson H Goldberg
Journal:  Hernia       Date:  2005-10-22       Impact factor: 4.739

3.  Novel technique of development of human derived acellular dermal matrix.

Authors:  Felipe Salinas; David Robla; Álvaro Meana; Marta Pevida; Gonzalo Martinez Magide; Cristina Sánchez Nuño; Luis Martín Suárez; Aurora Astudillo González; Eva García; Luis Junquera
Journal:  Cell Tissue Bank       Date:  2021-09-01       Impact factor: 1.522

4.  Effect of suture material on tensile strength and complication rate in abdominal fascial defects repaired with acellular dermal matrix.

Authors:  A A Winkler; M L Milburn; L H Holton; L T Holton; N H Goldberg; R P Silverman
Journal:  Hernia       Date:  2007-09-13       Impact factor: 4.739

5.  Ventral hernia repair using allogenic acellular dermal matrix in a swine model.

Authors:  R P Silverman; E N Li; L H Holton; K T Sawan; N H Goldberg
Journal:  Hernia       Date:  2004-12       Impact factor: 4.739

6.  Evaluation of dermal substitute in a novel co-transplantation model with autologous epidermal sheet.

Authors:  Guofeng Huang; Shizhao Ji; Pengfei Luo; Yunqing Zhang; Guangyi Wang; Shihui Zhu; Shichu Xiao; Zhaofan Xia
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  The component separation index: a standardized biometric identity in abdominal wall reconstruction.

Authors:  Michael R Christy; John Apostolides; Eduardo D Rodriguez; Paul N Manson; David Gens; Thomas Scalea
Journal:  Eplasty       Date:  2012-03-22

8.  Dermis, acellular dermal matrix, and fibroblasts from different layers of pig skin exhibit different profibrotic characteristics: evidence from in vivo study.

Authors:  Yanhai Zuo; Shuliang Lu
Journal:  Oncotarget       Date:  2017-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.